Doherty Catherine T.'s Form 4 filing
Quest Diagnostics Inc (DGX) · filed Dec 2, 2024
- Accession no.
- 0001022079-24-000206
- Filed
- Dec 2, 2024
- Trade date
- Nov 27, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.40M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Doherty Catherine T.CIK 0001520897 | Officer (EVP, Regional Businesses) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | Common Stock | MOption exerciseAcquired | +33,103 | $103.57 | +$3,428,477.71 | 101,515 | Direct | |
| Nov 27, 2024 | Common Stock | SSaleDisposed | −4,803 | $162.14 | −$778,758.42 | 96,712 | Direct | |
| Nov 27, 2024 | Common Stock | SSaleDisposed | −28,300 | $163.13 | −$4,616,579 | 68,412 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | Common Stock | MOption exerciseDisposed | −33,103 | $103.57 | −$3,428,477.71 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.